Siegfried Holding

Siegfried Holding Net Margin

The Net Profit Margin of Siegfried Holding (SFZN.SW) as of Oct 31, 2026 is 12.70 %. In the previous year, Net Profit Margin was 12.36 % — a change of 2.73% (higher).

Net Margin

12.70 %

YoY

2.73%

Last updated:

Net Profit Margin of Siegfried Holding is 2025 12.70 % . Net Profit Margin of Siegfried Holding was 2024 12.36 % . It decreases by 2.73% higher compared to the previous year.

For Siegfried Holding, the net margin of 12.7% is up versus 8.7% a few years ago.

The Siegfried Holding Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
7.09 CHF
Jan 1, 2019
6.38 CHF
Jan 1, 2020
7.20 CHF
Jan 1, 2021
8.67 CHF
Jan 1, 2022
12.73 CHF
Jan 1, 2023
8.87 CHF
Jan 1, 2024
12.36 CHF
Jan 1, 2025
12.70 CHF
The Siegfried Holding Net Margin history
YEARNet MarginYoY
12.70 %+2.73%
12.36 %+39.40%
8.87 %-30.31%
12.73 %+46.77%
8.67 %+20.40%
7.20 %+12.96%
6.38 %-10.06%
7.09 %+33.90%
5.29 %+36.17%
3.89 %-52.21%
8.14 %-33.47%
12.23 %+8,414.53%
0.14 %+153.14%
0.06 %+93.93%
0.03 %-156.63%
-0.05 %-58.53%
-0.12 %-51.93%
-0.26 %-265.93%
0.16 %+44.55%
0.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Siegfried Holding Stock analysis

What does Siegfried Holding do? Siegfried Holding AG generates revenue through the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates for pharmaceutical clients. The company provides contract development and manufacturing services for APIs, intermediates, and controlled substances, serving clients with research and development programs. Its drug products portfolio includes licensing and contract or co-development and manufacturing of oral solids and steriles. The firm targets pharmaceutical companies seeking to outsource production of treatments for hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia, bipolar disorders, and diabetes. Production facilities in Switzerland, Germany, France, Malta, the United States, and China support these operations. Siegfried Holding AG’s business model focuses on serving pharmaceutical clients who require specialized manufacturing capabilities for both drug substances and drug products. The company’s APIs and intermediates are developed for specific therapeutic areas, including cardiovascular conditions like hypertension and benign prostate hyperplasia, as well as neurological and psychiatric disorders such as depression, schizophrenia, and bipolar disorders. The firm’s manufacturing services are tailored to meet the needs of clients developing treatments for chronic conditions like diabetes and asthma. Contracts with pharmaceutical firms for these services form the core of the company’s revenue streams. The company’s production facilities across multiple countries enable it to serve a global client base. By offering both drug substance and drug product manufacturing, Siegfried Holding AG provides comprehensive solutions for pharmaceutical clients. Its services include contract development and manufacturing of APIs, intermediates, and controlled substances, alongside licensing and co-development of oral solid and sterile drug products. These offerings cater to clients seeking to outsource complex manufacturing processes for treatments targeting a wide range of medical conditions, from cardiovascular to neurological disorders. Siegfried Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Siegfried Holding stock

Net Profit Margin of Siegfried Holding is 12.70 % in 2025.

Net Profit Margin of Siegfried Holding changed from 12.36 % to 12.70 %, representing a 2.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Siegfried Holding since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Siegfried Holding with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Siegfried Holding

All Key Metrics — Siegfried Holding